科华生物(002022.SZ)：目前未开展机器人业务

Core Viewpoint - The company has not yet developed a robotics business, but its colloidal gold products, specifically the anti-HIV test kits, have been recognized by the WHO procurement list, indicating strong customer validation of its products [1] Company Developments - The company's subsidiary, Xi'an Tianlong, has a chikungunya virus RNA test kit (fluorescent PCR method) that has not yet applied for the National Medical Products Administration's medical device registration, and it is currently only available as a research reagent for customs and disease control applications [1] - The sales proportion of the chikungunya virus test kit is small and has not significantly impacted the company's consolidated revenue [1]